GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio Plus Co Ltd (XKRX:099430) » Definitions » EV-to-Revenue

Bio Plus Co (XKRX:099430) EV-to-Revenue : 3.79 (As of Jun. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bio Plus Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bio Plus Co's enterprise value is ₩235,672 Mil. Bio Plus Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩62,248 Mil. Therefore, Bio Plus Co's EV-to-Revenue for today is 3.79.

The historical rank and industry rank for Bio Plus Co's EV-to-Revenue or its related term are showing as below:

XKRX:099430' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.33   Med: 6.75   Max: 41.85
Current: 3.79

During the past 6 years, the highest EV-to-Revenue of Bio Plus Co was 41.85. The lowest was 3.33. And the median was 6.75.

XKRX:099430's EV-to-Revenue is ranked worse than
58.37% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.02 vs XKRX:099430: 3.79

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Bio Plus Co's stock price is ₩5080.00. Bio Plus Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,055.62. Therefore, Bio Plus Co's PS Ratio for today is 4.81.


Bio Plus Co EV-to-Revenue Historical Data

The historical data trend for Bio Plus Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio Plus Co EV-to-Revenue Chart

Bio Plus Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial - - - 9.31 5.74

Bio Plus Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.56 5.60 5.20 5.24 5.58

Competitive Comparison of Bio Plus Co's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Bio Plus Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio Plus Co's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio Plus Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bio Plus Co's EV-to-Revenue falls into.



Bio Plus Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bio Plus Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=235672.250/62247.75
=3.79

Bio Plus Co's current Enterprise Value is ₩235,672 Mil.
Bio Plus Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩62,248 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio Plus Co  (XKRX:099430) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bio Plus Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=5080.00/1055.619
=4.81

Bio Plus Co's share price for today is ₩5080.00.
Bio Plus Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,055.62.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio Plus Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bio Plus Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio Plus Co (XKRX:099430) Business Description

Traded in Other Exchanges
N/A
Address
Sagimakgol-ro 45th Street 14, Seongnam Woolim Lions Valley 2cha A-dong 180, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR
Bio Plus Co Ltd is engaged in the development of innovative biomedical and medical devices products through research on bio-material applications platform technology.

Bio Plus Co (XKRX:099430) Headlines

No Headlines